CPHI
Price:
$0.2333
Market Cap:
$4.00M
China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products primarily to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate and Ozagrel Sodium to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Alginic Sodium Dieste...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2002-04-17
Stock Exchange
AMEX
Ticker
CPHI
According to China Pharma Holdings, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.25. This represents a change of -82.74% compared to the average of -1.45 of the last 4 quarters.
The mean historical PE Ratio of China Pharma Holdings, Inc. over the last ten years is -8.27. The current -0.25 PE Ratio has changed 202.34% with respect to the historical average. Over the past ten years (40 quarters), CPHI's PE Ratio was at its highest in in the June 2020 quarter at 2.78K. The PE Ratio was at its lowest in in the March 2021 quarter at -62.37.
Average
-8.27
Median
-2.49
Minimum
-30.76
Maximum
-0.66
Discovering the peaks and valleys of China Pharma Holdings, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.15%
Maximum Annual PE Ratio = -0.66
Minimum Annual Increase = -91.26%
Minimum Annual PE Ratio = -30.76
Year | PE Ratio | Change |
---|---|---|
2023 | -0.66 | -73.07% |
2022 | -2.47 | -91.26% |
2021 | -28.24 | -8.20% |
2020 | -30.76 | 1.15% |
2019 | -2.45 | -52.96% |
2018 | -5.22 | 162.86% |
2017 | -1.98 | -67.83% |
2016 | -6.17 | 177.83% |
2015 | -2.22 | -11.34% |
2014 | -2.50 | -33.21% |
The current PE Ratio of China Pharma Holdings, Inc. (CPHI) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-10.46
5-year avg
-12.92
10-year avg
-8.27
China Pharma Holdings, Inc.’s PE Ratio is less than Universe Pharmaceuticals INC (-0.13), greater than Sonoma Pharmaceuticals, Inc. (-10.68), less than Acorda Therapeutics, Inc. (-0.00), less than Akanda Corp. (-0.00), less than Halo Collective Inc. (-0.00), greater than Alimera Sciences, Inc. (-20.50), less than China SXT Pharmaceuticals, Inc. (-0.02), less than Petros Pharmaceuticals, Inc. (-0.18), greater than Biofrontera Inc. (-0.31), greater than Guardion Health Sciences, Inc. (-0.71), greater than Shuttle Pharmaceuticals Holdings, Inc. (-2.37), less than Green Cures & Botanical Distribution Inc. (1.21), less than Cann American Corp. (0.49), greater than Rimrock Gold Corp. (-31.07), greater than Galexxy Holdings, Inc. (-5.59), less than Indoor Harvest Corp (-0.12), less than Mallinckrodt plc (-0.00), less than Lifecore Biomedical, Inc. (21.41), greater than Lucy Scientific Discovery Inc. (-0.72), greater than Adamis Pharmaceuticals Corporation (-0.47),
Company | PE Ratio | Market cap |
---|---|---|
-0.13 | $5.13M | |
-10.68 | $3.83M | |
-0.00 | $821.03K | |
-0.00 | $2.09M | |
-0.00 | $895.00 | |
-20.50 | $301.29M | |
-0.02 | $1.95M | |
-0.18 | $3.05M | |
-0.31 | $4.60M | |
-0.71 | $4.20M | |
-2.37 | $3.03M | |
1.21 | $522.63K | |
0.49 | $4.43M | |
-31.07 | $273.27K | |
-5.59 | $4.77M | |
-0.12 | $320.57K | |
-0.00 | $4.52M | |
21.41 | $140.12M | |
-0.72 | $906.91K | |
-0.47 | $7.25M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like China Pharma Holdings, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like China Pharma Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is China Pharma Holdings, Inc.'s PE Ratio?
How is the PE Ratio calculated for China Pharma Holdings, Inc. (CPHI)?
What is the highest PE Ratio for China Pharma Holdings, Inc. (CPHI)?
What is the 3-year average PE Ratio for China Pharma Holdings, Inc. (CPHI)?
What is the 5-year average PE Ratio for China Pharma Holdings, Inc. (CPHI)?
How does the current PE Ratio for China Pharma Holdings, Inc. (CPHI) compare to its historical average?